Rat hepatoma Reuber H-35 cells produce a unique compound designated as Fr.B-25, a 2-cell stagespecific inhibitor of the cleavage of preimplantation mouse embryos cultured in vitro. Here, we identified Fr.B-25 as a purine nucleoside, 5 -deoxy-5 -methylthioadenosine (MTA), by mass spectroscopic analysis. All of the biological activities examined of authentic MTA on the development of mouse zygotes were indistinguishable from those of Fr.B-25. The mechanism of MTA action in the development of preimplantation mouse embryos was probably different from those of hypoxanthine and adenosine, which are well-characterized purine nucleosides that act as inhibitors of the cleavage of mouse 2-cell embryos. From the shared molecular and biological properties of Fr.B-25 and MTA, we concluded that Fr.B-25 is MTA. To the best of our knowledge, this is the first delineation of the effect of MTA on the development of preimplantation mammalian embryos cultured in vitro.
Introduction
The preimplantation development of mammalian embryos is affected by several nutritional and environmental factors. Soluble growth factors and cytokines produced by preimplantation embryos (Rappolee et al., 1988; Werb, 1990; Sharkey et al., 1995) and the epithelial cells of the fallopian tube (Sakkas and Trounson, 1990; Minami et al., 1992) and of the uterus (Brigstock et al., 1989; Sakkas and Trounson, 1990; Pampfer et al., 1991) have been reported to control early embryonic development. In all species studied, developmental arrest occurred at specific cell-stages in cultured embryos including mouse 2-cell (Goddard & Pratt, 1983; Bolton et al., 1984) , human 4-to 8-cell (Braude et al., 1988) , hamster 2-cell (Bavister, 1988) , sheep and goat 8-to 16-cell (Sakkas et al., 1989) , cow 4-to 8-cell (Camous et al., 1984) , and pig 4-cell (Davis, 1985) stages. During these stages, the activation of transcription by the embryonic genome occurs (Latham, 1999; Minami et al., 2007) . However, this developmental arrest has hampered the generation of in vitro produced preimplantation embryos for animal husbandry, the generation of transgenic animals, and assisted reproductive technology for infertility. In order to analyze the mechanisms underlying these cleavage blocks, substances that act as inducers or inhibitors of the cleavage block are very valuable.
Serum and serum preparations, such as fetal calf serum and bovine serum albumin (BSA), have been widely used as supplements for culture media to support the in vitro development of preimplantation mammalian embryos. The liver is the major organ that synthesizes and secretes serum or serum fractions, some of which are known to affect the early development of mammalian embryos (Saito et al., 1984; Ogawa et al., 1987) . However, the effects of substances synthesized by hepatocytes on the development of preimplantation embryos are not fully understood. Assuming that hepatocytes, including hepatoma cells, provide an excellent source for finding either positive or negative regulators for the development of mammalian embryos, we have investigated the effects of medium conditioned using rat hepatoma cells, Reuber H-35 (Kobayashi et al., 1996 (Kobayashi et al., , 1997 (Kobayashi et al., , 2009 Kobayashi & Horiuchi, 1998) and BRL (Kobayashi et al., 2009) , on the development of mouse and bovine embryos cultured in vitro. The cell-conditioned medium (CM) exerted beneficial effects on the development of preimplantation embryos (Kobayashi et al., 1997 (Kobayashi et al., , 2009 Kobayashi & Horiuchi, 1998) . On the other hand, we also found a compound, Fr.B-25, purified from the Mr < 10,000 fraction of Reuber CM that inhibits the development of mouse zygotes at the 2-cell stage (Kobayashi et al., 1996) .
In this study, we identified Fr.B-25 as a purine nucleoside, 5 -deoxy-5 -methylthioadenosine (MTA), using mass spectroscopic analysis and compared the biological activities of Fr.B-25, MTA, and other purines on the development of mouse embryos cultured in vitro.
Materials and methods

Experimental design
The first experiment was designed to identify the structure of Fr.B-25 by mass spectroscopic analysis. Secondly, the biological activities of Fr. B-25, an authentic compound for Fr.B-25 identified by mass spectroscopic analysis, and its structurally related compounds on the development of mouse zygotes cultured in vitro were compared. Thirdly, we tried to investigate the mode of action of the identified compound as Fr.B-25 underlying the 2-cell blocking effect on mouse embryos.
Media
M2 (Quinn et al., 1982) was supplemented with 4 mg/ml BSA (A4378, Sigma Chemical Company), and modified Whitten's medium (WM) (Hoppe, 1985) was supplemented with 3 mg/ml BSA (A7030, Sigma Chemical Company). Phenol red was not added to M2 or WM. Dulbecco's modified Eagle's medium (DMEM) was purchased from Sigma.
Embryo collection
Induction of superovulation and subsequent mating of 6-to 12-week-old virgin female CD-1 mice (random bred, Swiss, Charles River Japan) were performed as described previously (Kobayashi et al., 1996) . Zygotes were flushed in M2 from excised oviducts 21-23 h after hCG injection. Cumulus cells were removed from the zygotes by hyaluronidase treatment (150 units/ml in M2 without BSA, Type I-S, Sigma Chemical Company). Two-cell embryos were flushed in M2 from excised oviducts 41-42 h after hCG injection. All animal procedures conformed to the Guidelines for the Care and Use of Laboratory Animals of Akita Prefectural University.
Culture of hepatoma cells and embryos
Rat hepatoma Reuber H-35 cells were routinely maintained in DMEM supplemented with heatinactivated 2% fetal calf serum (HyClone).
The zygotes were cultured in 0.5 or 1 ml of fresh WM supplemented with MTA (Sigma Chemical Company), adenosine (Wako Pure Chemicals), or hypoxanthine (Wako Pure Chemicals) in the presence of both 3 mg/ml BSA and 50 μM EDTA in 24-well dishes (Asahi Glass) or 4-well dishes (Nunc). EDTA (50 μM) was added because low concentrations (10-50 μM) of this compound have been demonstrated to promote the development of CD-1 zygotes cultured in vitro (Abramczuk et al., 1977) . Because the hypoxanthineinduced 2-cell block was reversed by dibutyryl cyclic adenosine monophosphate (dbcAMP), a cAMP analogue, at 100 μM (Fissore et al., 1992) , dbcAMP (Sigma Chemical Company) was used at this concentration. Development to the 2-cell, 4-to 8-cell, and blastocyst stages was observed at 24, 48, and 120 h, respectively, after the start of in vitro culture.
When obtaining 4-to 8-cell embryos, 2-cell embryos developed in vivo were cultured in vitro with WM containing 3 mg/ml BSA without EDTA for ∼22 h. Thereafter, 4-to 8-cell embryos were transferred to 0.5 ml of fresh WM supplemented with one of the nucleosides in the presence of 3 mg/ml BSA without EDTA. Development to the morula to blastocyst and blastocyst stages was observed at 24 h and 72 h, respectively, after start of the experiment.
Less than 30 embryos were cultured in each well. The results of each experiment were analyzed by the chi-squared test.
Preparation, ultrafiltration, and column chromatography of medium conditioned using hepatoma cells
Cell-conditioned WM without BSA was obtained by culture with Reuber H-35 cells as described previously (Kobayashi et al., 1996) . In brief, confluent Reuber H-35 cells in 143 cm 2 dishes were cultured with 40 ml of WM without BSA, penicillin, or streptomycin for 24 h. Because penicillin was eluted in fractions beside the fraction containing Fr.B-25, it was not added to WM. CM was separated by centrifugal ultrafiltration (Centricon Plus-80, < 10,000 Mr cut off; Millipore) into a subfraction, i.e. the pass-through fraction as the Mr < 10,000. This fraction was stored at −20 • C before use.
The Mr < 10,000 fraction was further applied to preparative reversed-phase column chromatography to obtain Fr.B-25 in accordance with the method described previously (Kobayashi et al., 2009) . The fractions containing Fr.B-25 were lyophilized to remove organic solvents. For embryo culture, the lyophilites were reconstituted with WM to a half of their original volumes.
Analytical reversed-phase column chromatography and high resolution-mass spectroscopic analyses (LC-MS) and tandem mass spectroscopic analysis
Fr.B-25 was further applied to LC-MS analysis. Analytical reversed-phase HPLC (octadecylsilane column, 2 mm × 150 mm, Nomura Chemical, Seto, Japan) was carried out with elution of the column using a linear gradient of acetonitrile with 0.05% perfluorobutanoic acid. High resolutional electrospray ionization mass spectroscopy (HR-ESI-MS) analysis of compounds separated by HPLC was carried out in the positiveion mode on a JEOL MS-700 (JEOL). Fr.B-25 was also subjected to LC-ESI-MS/MS analysis in the positiveion mode (API2000 LC-MS/MS system, Applied Biosystems, Japan).
Results
Identification of Fr.B-25 as MTA by mass spectroscopic analysis
Approximately 2 mg of Fr.B-25 was purified from ∼4000 ml of the Mr < 10,000 fraction by preparative reversed-phase column chromatography. First, a portion (∼3 μg) of purified Fr.B-25 was further applied to analytical reversed-phase HPLC and the molecular weight of Fr.B-25 was determined by high-resolution MS (HR-MS). As shown in Fig. 1a , Fr.B-25 eluted from the column as an apparent peak at about 9.3 min. 
Positive ion HR-MS of Fr.B-25 showed (M+1)
+ at m/z 298.0927 (Fig. 1b) for a possible molecular formula of C 11 H 15 O 3 N 5 S (calc. 298.0973). Considering that the biological activity of Fr.B-25 resembles that of purine nucleosides in our previous study (Kobayashi et al., 1996) and its UV spectrum property (λ max at 260 nm, data not shown), Fr.B-25 was suggested to be a purine nucleoside, 5 -deoxy-5 -methylthioadenosine (MTA).
To confirm the structure of Fr.B-25, ESI-MS/MS analysis of Fr.B-25 and MTA was performed (Fig. 2) . As shown in Fig. 2a , the ESI-MS spectrum for authentic MTA showed (M+1) + at m/z 298 as a parent ion together with its sodium complex at m/z 320 (M + Na) + . Product ions found with Fr.B-25 from m/z 298 were found at m/z 136, 119, 92, 75, and 61 (Fig. 2c) , and these obtained ions were exactly identical to those of authentic MTA (Fig. 2b) . Therefore, it was clearly shown that Fr.B-25 was MTA.
Inhibitory activity of authentic MTA and other purines on the development of cleaving 2-cell embryos
In preimplantation mouse embryos, micromolar concentrations of the purines hypoxanthine and adenosine have been shown to block the second or third cleavage of several strains of mouse embryos cultured in vitro (Loutradis et al., 1987; Nureddin et al., 1990) . Thus, the following experiment was conducted to determine and compare the effect of MTA with those of hypoxanthine and adenosine on the development of CD-1 zygotes cultured in vitro.
When a 2-day culture with fresh WM containing 50 μM EDTA was used as a control, 96.7% of the 2-cell embryos cultured from zygotes developed to the 4-to 8-cell stage (Table 1) . Fr.B-25 significantly inhibited (p < 0.001) the cleavage of embryos at the 2-or 3-cell stage, i.e. 62.2% of the 2-cell embryos developed to the 4-to 8-cell stage. By means of reversed-phase column chromatographic analysis, the content of MTA in Fr.B-25 was estimated to be about 2 to 3 μM. Under these conditions, the dose-dependent inhibitory effect of authentic MTA on the cleavage of 2-cell embryos was examined. Significant (p < 0.01) inhibitory action was detected at concentrations as low as 0.5 μM; 85.2% of the 2-cell embryos developed to the 4-to 8-cell stage. By culturing with 50 μM MTA, 41.8% (p < 0.001) of the 2-cell embryos developed to the same stage. Inhibitory activities on the development of 2-cell embryos at micromolar levels were also detected using other purines, specifically adenosine and hypoxanthine, whereas these purines at 50 μM potently inhibited the development more strongly than 50 μM MTA. These findings demonstrated that MTA inhibits the development of zygotes at the 2-cell stage as efficiently as Fr.B-25, and the effective concentrations of MTA were similar to those of other purines.
Dibutyryl cAMP did not reverse the inhibitory effect of MTA on the development of 2-cell embryos Fissore et al. (1992) reported that hypoxanthineinduced 2-cell block was reversed by adding 100 μM dbcAMP, a cAMP analog, to the culture medium from the start of cultivation of random-bred mouse zygotes. Therefore, to investigate differences in the inhibitory actions among MTA, adenosine, and hypoxanthine, the effect of dbcAMP at 100 μM on the 2-cell blocking effect of these compounds was analysed ( Table 2 ). The addition of dbcAMP from the start of cultivation of zygotes (22-24 h after hCG) did not affect development in the control culture (WM + dbcAMP), as reported previously (Nureddin et al., 1990; Fissore et al., 1992) . On the contrary, the inhibitory activity of 5 μM hypoxanthine on the development of zygotes (19.7% development to blastocysts) was partially alleviated by supplementation with dbcAMP (32.9% development to blastocysts, p = 0.097), whereas those of Fr.B-25, MTA, and adenosine were not affected even in the presence of dbcAMP. a CD-1 zygotes were cultured with or without (WM) Fr.B-25 or one of the purines in the presence of 3 mg/ml BSA and 50 μM EDTA. The concentrations of purines and dbcAMP were 5 μM and 100 μM, respectively. b Development to the 2-cell, 4-to 8-cell, and blastocyst stages was observed at 24, 48, and 120 h, respectively, after the start of in vitro culture. (100) 44 (100) a CD-14-to 8-cell embryos were cultured with Fr.B-25 or one of the purines in the presence of 3 mg/ml BSA without EDTA. Control embryos were cultured in fresh medium containing 3 mg/ml BSA and 50 μM EDTA (Control). b Development to the morula to blastocyst and blastocyst stages was observed at 24 h and 72 h, respectively, after start of the experiment. c Significantly different from the control; p < 0.001.
The effect of MTA and other purines on subsequent development of 4-to 8-cell embryos
We reported previously that the subsequent development of 4-to 8-cell embryos (Kobayashi et al., 1996) and morulae (Kobayashi et al., 1997) obtained from CD-1 mice was only inhibited slightly by co-culture with Reuber H-35 cells or with its CM, and Fr.B-25 was considered as a 2-cell stage-specific inhibitor of the cleavage of preimplantation mouse embryos. In order to clarify the developmental stage-specific effect of MTA, 4-to 8-cell embryos were cultured with MTA or other purines. As indicated in Table 3 , almost no effect of Fr.B-25 and MTA at 5 and 50 μM on the subsequent development of 4-to 8-cell embryos to blastocysts (a 72-h period) was detected. Similarly, hypoxanthine exerted no effect. However, in the presence of 5 and 50 μM adenosine, degeneration of embryos occurred at the blastocyst stage, and no blastocysts were observed following a 72-h treatment. The rates of morphologically normal blastocysts after a 48-h period of 5 and 50 μM adenosine treatment were 46.0% and 6.7%, respectively, indicating that a rapid degeneration of embryos occurred during the blastocyst stage.
Discussion
Rat hepatoma Reuber H-35 cells produce a unique compound designated as Fr.B-25, a 2-cell stage-specific inhibitor of the cleavage of mouse embryos cultured in vitro. Here, we identified Fr.B-25 as MTA from the complete identity of their molecular properties and almost identical biological properties.
MTA is a by-product of polyamine biosynthesis in mammalian cells (Pegg and Williams-Ashman, 1969 ). To date, divergent activities of MTA at micromolar levels have been reported. MTA inhibits the proliferation of various types of mammalian cells, including mouse lymphoma cells (Wolford et al., 1981; Riscoe et al., 1984) , SV40-transformed mouse fibroblasts (Pegg et al., 1981) , hamster BHK21 cells (Raina et al., 1982) , human glioma cells (Miyaji et al., 1995) , and human hepatoma cells (Yang et al., 2004) . In addition, MTA inhibited the differentiation of mouse Friend erythroleukemic cells (Di Fiore et al., 1984) and stimulated the induction of apoptosis in human leukemia U937 cells (Lee & Cho, 1998) , human hepatoma Hep G2 cells (Yang et al., 2004) , and human colon cancer HT-29 and RKO cells (Li et al., 2009b) .
To the best of our knowledge, this is a first report that MTA inhibited the in vitro development of preimplantation mouse embryos. Two points should be discussed regarding MTA action. First, how does MTA exert the cleavage blocking effect? The growth arrest produced by MTA in mouse lymphoma S49 cells is primarily due to the inhibition of cAMP phosphodiesterase and the subsequent increase in intracellular cAMP levels (Riscoe et al., 1984) . However, in the present study (Table 2 ), the addition of dbcAMP to maintain intracellular cAMP as dbcAMP at 100 μM to the control culture of mouse zygotes (WM + dbcAMP) did not result in developmental arrest at the 2-cell stage, suggesting that cAMP elevation is probably unrelated to the blocking effect of MTA, adenosine, and hypoxanthine. On the other hand, Fissore et al. (1992) reported that dbcAMP at 100 μM reversed the 2-cell blocking effect of hypoxanthine, which is well-characterized purine nucleoside that acts as an inhibitor of the cleavage of mouse 2-cell embryos (Loutradis et al., 1987; Nureddin et al., 1990) , and they concluded that hypoxanthine suppresses a cAMP-dependent process. Here, the relatively strong inhibitory effect of hypoxanthine was partially alleviated by adding dbcAMP. Conversely, the alleviation by dbcAMP addition was not observed even with relatively weak inhibitory effect of MTA (Table 2) . Therefore, we considered that the mechanism of MTA action is different from that of hypoxanthine, i.e., the inhibitory effect of MTA is likely to be exerted without the inhibition of a cAMP-dependent process. MTA is known as a potent inhibitor of the fibroblast growth factor (FGF)-stimulated tyrosine kinase activity of FGF receptors (Maher, 1993; Miyaji et al., 1995) , protein carboxymethyltransferase (Pintucci et al., 1996; Lee & Cho, 1998) , and DNA methylase (Vandenbark et al., 1980) . These effects of MTA or other novel regulatory effects seem to induce its inhibitory activity against the development of zygotes.
Secondly, why does MTA specifically inhibit the cleavage of 2-cell embryos? The 2-cell stage-specific inhibition by hypoxanthine indicated here is also a new finding. As reviewed by Minami et al. (2007) , zygotic genome activation occurs during the 2-cell stage in mouse embryos; therefore, this stage is critical for several nutritional and environmental factors particularly in in vitro culture, including inorganic constituents (Abramczuk et al., 1977; Erbach et al., 1994) , energy sources (Chatot et al., 1989) , growth factors (Lu et al., 1994) , and reactive oxygen (Lu et al., 1994) . MTA and hypoxanthine were likely to be involved in zygotic genome activation. As indicated, we broadly defined the mode of MTA action underlying the 2-cell blocking effect on mouse embryos. Further work will be required to determine the exact mechanisms of MTA action.
While the inhibitory effects of hypoxanthine and adenosine on the developing 2-cell mouse embryos have been well characterized (Loutradis et al., 1987; Nureddin et al., 1990; Downs & Dow, 1991) ; the effect of these purines on the subsequent development of 4-to 8-cell embryos was not reported. Although exposure to adenosine from the 4-to 8-cell stage induced the degeneration of embryos at the blastocyst stage (Table 3) , MTA and hypoxanthine specifically inhibited the cleavage of 2-cell embryos during the preimplantation period. This finding also indicated that the effects of MTA and hypoxanthine are different from that of adenosine on the development of preimplantation mouse embryos. Several studies have shown that extracellular adenosine induces cell death in a variety of cell types, including human hepatoma (Bar-Yehuda et al., 2008) , human glioma (Grbovic et al., 2002) , and human arterial smooth muscle cells (Peyot et al., 2000) , through adenosine receptors or adenosine transporters (Eltzschig, 2009) . Mouse blastocysts also express adenosine receptors, as reported by Kawaguchi et al. (2009) . Degeneration of blastocysts induced by adenosine was likely to be involved in a similar manner to that demonstrated in these reports.
Methylthioadenosine phosphorylase (MTAP) plays a major role in polyamine metabolism and the salvage of adenine and methionine by catalyzing the phosphorylation of MTA to methylthioribose-1-phosphate. While MTAP is expressed abundantly in normal cells (Olopade et al., 1995) , many malignant cells lack MTAP activity (Tang et al., 2000; Garcia-Castellano et al., 2002) . As reported by Savarese et al. (1983) , a lack of MTAP in tumor cells probably leads to the excretion of MTA into the culture medium, owing to their inability to metabolize MTA. In fact, MTA is detectable in the urine of patients with malignant cancer (Li et al., 2009a) . We found previously that the content of Fr.B-25 in Reuber CM is 19-fold higher than that in BRL CM, indicating the productivity of Fr.B-25 is different even in rat hepatoma cell lines (Kobayashi et al., 2009 ). In addition, human hepatoma Hep G2 cells exerted almost no effect to the development of CD-1 zygotes cultured in vitro, suggesting that Hep G2 cells secrete little MTA, as we also reported (Kobayashi et al., 1996) . However, it is unclear whether hepatoma cells other than Reuber H-35, BRL, or Hep G2, in which the expression of MTAP activity still unknown, secrete a significant amount of MTA. We considered that medium conditioned by established cell lines lacking MTAP activity may also exert the 2-cell blocking effect via MTA. On the other hand, physiological extracellular concentrations of purines, such as adenosine, are at submicromolar levels (Hasko et al., 2008) and correspond well with effective concentrations of purines in 2-cell blocking (Table 1) . It is noteworthy that the Mr < 1000 fraction of human cord serum significantly reduced embryonic development in B6C3F1 mice, particularly at the 2-cell stage (Ogawa et al., 1987) . Comparing the levels of MTA, adenosine, and hypoxanthine in serum or secretory fluid of genital tracts, including oviducts or uteri, of between fertile and infertile females could provide valuable information on the effects of these purines in vivo.
Taken together, we identified the active compound in Fr.B-25 as MTA. In view of the present findings, in addition to hypoxanthine and adenosine, MTA is useful as a tool to dissect the mechanism regulating the preimplantation development of mouse embryos. Further studies on MTA or other purines are crucial for understanding the causes of infertility in mammals.
